Delivery Order SPE2DB22D2206-SPE2DB25FFF12
Award Date
1/23/25
Potential Completion Date
2/13/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product, with a completion date of January 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not associated with any set-aside designation, indicating open competition....
This federal contract award is a Delivery Order valued at $17,968.39, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication, with a performance period ending on June 17, 2025. The contract is a Firm Fixed Price arrangement, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567957715 WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of Welireg 40 mg tablets. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB25FEW10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $35,936.78, is a delivery order contract with a firm fixed price pricing type. The contract covers the procurement of WELIREG 40 MG TABLET 90S, a pharmaceutical product, with a period of performance through January 17, 2025. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of WELIREG 40 MG TABLET 90S. The contract, valued at $17,368.14, was awarded by the Medical Supply Chain division of the Defense Department. It is a firm fixed-price delivery order contract with a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
This federal contract award, identified as SPE2DB22D3501|SPE2DB25FTN89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,968.39, is for the delivery of the medication WELIREG 40 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization registered in...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $17,968.39 and a period of performance ending on July 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...